Association of the placenta accreta spectrum score and estimated blood loss in placenta accreta spectrum patients with placenta previa: a retrospective cohort study.


Journal

Journal of anesthesia
ISSN: 1438-8359
Titre abrégé: J Anesth
Pays: Japan
ID NLM: 8905667

Informations de publication

Date de publication:
12 2022
Historique:
received: 01 04 2022
accepted: 14 09 2022
pubmed: 30 9 2022
medline: 19 11 2022
entrez: 29 9 2022
Statut: ppublish

Résumé

The placenta accreta spectrum (PAS) score calculated by the scoring system may predict patients with PAS. We aim to find the relationship between estimated blood loss and the PAS score. Further, find the inflection point, identify PAS patients with placenta previa who were at risk for major bleeding. The PAS patients with placenta previa, as diagnosed by color Doppler ultrasound, were divided into two groups according to their PAS scores using a new scoring system. Blood loss, transfusion requirements, the rate of Intra-Abdominal Balloon Occlusion (IABO), and other indicators were analyzed between groups. The estimated blood loss, intraoperative transfusion, postoperative transfusion, operation time, and hospitalization time significantly increased in the group with a PAS score ≥ 9 (P < 0.05). The inflection point analysis revealed that a significant increase in estimated blood loss occurred when the PAS score was beyond 10 (crude) or 6 (adjusted for age, body mass index, and IABO). There was a non-linear relationship between estimated intraoperative blood loss and PAS score. When the PAS score was greater than 9, hemorrhage, the risk of major bleeding, the need for transfusions, and the placement of an abdominal aortic balloon all increase significantly.

Identifiants

pubmed: 36173551
doi: 10.1007/s00540-022-03108-w
pii: 10.1007/s00540-022-03108-w
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

715-722

Informations de copyright

© 2022. The Author(s) under exclusive licence to Japanese Society of Anesthesiologists.

Références

Jauniaux E, Ayres-de-Campos D. FIGO consensus guidelines on placenta accreta spectrum disorders: introduction. Int J Gynaecol Obstet. 2018;140:261–4. https://doi.org/10.1002/ijgo.12406 .
doi: 10.1002/ijgo.12406 pubmed: 29405322
Jauniaux E, Silver RM, Matsubara S. The new world of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2018;140:259–60. https://doi.org/10.1002/ijgo.12433 .
doi: 10.1002/ijgo.12433 pubmed: 29405318
Angstmann T, Gard G, Harrington T, Ward E, Thomson A, Giles W. Surgical management of placenta accreta: a cohort series and suggested approach. Am J Obstet Gynecol. 2010;202(38):e1-9. https://doi.org/10.1016/j.ajog.2009.08.037 .
doi: 10.1016/j.ajog.2009.08.037
Machado LSM. Emergency peripartum hysterectomy: incidence, indications, risk factors and outcome. N Am J Med Sci. 2011;3:358–61. https://doi.org/10.4297/najms.2011.358 .
doi: 10.4297/najms.2011.358 pubmed: 22171242 pmcid: 3234143
Chong Y, Zhang A, Wang Y, Chen Y, Zhao Y. An ultrasonic scoring system to predict the prognosis of placenta accreta: a prospective cohort study. Medicine (Baltimore). 2018;97: e12111. https://doi.org/10.1097/MD.0000000000012111 .
doi: 10.1097/MD.0000000000012111
Wang Y, Zhou Y, Zeng L, Chen L, Zhao Y. Analysis of risk factors for massive intraoperative bleeding in patients with placenta accreta spectrum. BMC Pregnancy Childbirth. 2022;22:116. https://doi.org/10.1186/s12884-022-04391-x .
doi: 10.1186/s12884-022-04391-x pubmed: 35148709 pmcid: 8832829
Chen L, Wang X, Wang H, Li Q, Shan N, Qi H. Clinical evaluation of prophylactic abdominal aortic balloon occlusion in patients with placenta accreta: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2019;19:30. https://doi.org/10.1186/s12884-019-2175-0 .
doi: 10.1186/s12884-019-2175-0 pubmed: 30646863 pmcid: 6332886
Tokue H, Tokue A, Tsushima Y, Kameda T. Safety and efficacy of aortic vs internal iliac balloon occlusion for cesarean delivery in coexisting placenta accreta and placenta previa. Cardiovasc Intervent Radiol. 2020;43:1277–84. https://doi.org/10.1007/s00270-020-02548-9 .
doi: 10.1007/s00270-020-02548-9 pubmed: 32533311
Lu R, Chu R, Wang Q, Xu Y, Zhao Y, Tao G, Li Q, Ma Y. Role of abdominal aortic balloon placement in planned conservative management of placenta previa with placenta increta or percreta. Front Med (Lausanne). 2021;8:767748. https://doi.org/10.3389/fmed.2021.767748 .
doi: 10.3389/fmed.2021.767748
Matsubara S. Letter to ‘intermittent aortic balloon occlusion combined with cesarean section for the treatment of patients with placenta previa complicated by placenta accreta: a retrospective study’: some concerns. J Obstet Gynaecol Res. 2019;45:240–1. https://doi.org/10.1111/jog.13838 .
doi: 10.1111/jog.13838 pubmed: 30288864
Nieto-Calvache AJ, Aryananda RA. The first step to evaluate the usefulness of arterial occlusion in placenta accreta spectrum is to establish its indications. Acta Obstet Gynecol Scand. 2021. https://doi.org/10.1111/aogs.14307 .
doi: 10.1111/aogs.14307 pubmed: 34907527
Chen M, Liu X, You Y, Wang X, Li T, Luo H, Qu H, Xu L. Internal iliac artery balloon occlusion for placenta previa and suspected placenta accreta: a randomized controlled trial. Obstet Gynecol. 2020;135:1112–9. https://doi.org/10.1097/AOG.0000000000003792 .
doi: 10.1097/AOG.0000000000003792 pubmed: 32282608
Kim J-W, Lee Y-K, Chin J-H, Kim S-O, Lee M-Y, Won H-S, Choi W-J. Development of a scoring system to predict massive postpartum transfusion in placenta previa totalis. J Anesth. 2017;31:593–600. https://doi.org/10.1007/s00540-017-2365-8 .
doi: 10.1007/s00540-017-2365-8 pubmed: 28466102
Kang J, Kim HS, Lee EB, Uh Y, Han KH, Park EY, Lee HA, Kang DR, Chung IB, Choi SJ. Prediction model for massive transfusion in placenta previa during cesarean section. Yonsei Med J. 2020;61:154–60. https://doi.org/10.3349/ymj.2020.61.2.154 .
doi: 10.3349/ymj.2020.61.2.154 pubmed: 31997624 pmcid: 6992462
Dang X, Zhang L, Bao Y, Xu J, Du H, Wang S, Liu Y, Deng D, Chen S, Zeng W, Feng L, Liu H. Developing and validating nomogram to predict severe postpartum hemorrhage in women with placenta previa undergoing cesarean delivery: a multicenter retrospective case–control study. Front Med (Lausanne). 2021;8:789529. https://doi.org/10.3389/fmed.2021.789529 .
doi: 10.3389/fmed.2021.789529
Chen C, Liu X, Chen D, Huang S, Yan X, Liu H, Chang Q, Liang Z. A risk model to predict severe postpartum hemorrhage in patients with placenta previa: a single-center retrospective study. Ann Palliat Med. 2019;8:611–21. https://doi.org/10.21037/apm.2019.09.04 .
doi: 10.21037/apm.2019.09.04 pubmed: 31594367
Chen D, Xu J, Ye P, Li M, Duan X, Zhao F, Liu X, Wang X, Peng B. Risk scoring system with MRI for intraoperative massive hemorrhage in placenta previa and accreta. J Magn Reson Imaging. 2020;51:947–58. https://doi.org/10.1002/jmri.26922 .
doi: 10.1002/jmri.26922 pubmed: 31507024
Matsubara S, Takahashi H, Baba Y. Letter to ‘Scoring model to predict massive post-partum bleeding in pregnancies with placenta previa: a retrospective cohort study’: the best scoring model may depend on the situation. J Obstet Gynaecol Res. 2018;44:1186–7. https://doi.org/10.1111/jog.13616 .
doi: 10.1111/jog.13616 pubmed: 29570918
Li K, Zou Y, Sun J, Wen H. Prophylactic balloon occlusion of internal iliac arteries, common iliac arteries and infrarenal abdominal aorta in pregnancies complicated by placenta accreta: a retrospective cohort study. Eur Radiol. 2018;28:4959–67. https://doi.org/10.1007/s00330-018-5527-7 .
doi: 10.1007/s00330-018-5527-7 pubmed: 29872910
Wu Q, Liu Z, Zhao X, Liu C, Wang Y, Chu Q, Wang X, Chen Z. Outcome of pregnancies after balloon occlusion of the infrarenal abdominal aorta during caesarean in 230 patients with placenta praevia accreta. Cardiovasc Intervent Radiol. 2016;39:1573–9. https://doi.org/10.1007/s00270-016-1418-y .
doi: 10.1007/s00270-016-1418-y pubmed: 27439624 pmcid: 5052309
Papillon-Smith J, Hobson S, Allen L, Kingdom J, Windrim R, Murji A. Prophylactic internal iliac artery ligation versus balloon occlusion for placenta accreta spectrum disorders: a retrospective cohort study. Int J Gynaecol Obstet. 2020;151:91–6. https://doi.org/10.1002/ijgo.13256 .
doi: 10.1002/ijgo.13256 pubmed: 32506473
Sun W, Duan S, Xin G, Xiao J, Hong F, Hong H, Wu Y, Xu Y. Safety and efficacy of preoperative abdominal Aortic balloon occlusion in placenta increta and/or percreta. J Surg Res. 2018;222:75–84. https://doi.org/10.1016/j.jss.2017.10.002 .
doi: 10.1016/j.jss.2017.10.002 pubmed: 29273378
Xie L, Wang Y, Luo F-Y, Man Y-C, Zhao X-L. Prophylactic use of an infrarenal abdominal aorta balloon catheter in pregnancies complicated by placenta accreta. J Obstet Gynaecol. 2017;37:557–61. https://doi.org/10.1080/01443615.2017.1291588 .
doi: 10.1080/01443615.2017.1291588 pubmed: 28366073
Cousins C. Medical radiation and pregnancy. Health Phys. 2008;95:551–3. https://doi.org/10.1097/01.HP.0000327647.74948.49 .
doi: 10.1097/01.HP.0000327647.74948.49 pubmed: 18849689
Murji A, Crosier R, Rasuli P. Non-obstetric diagnostic imaging in pregnancy. CMAJ. 2015;187:1309. https://doi.org/10.1503/cmaj.140901 .
doi: 10.1503/cmaj.140901 pubmed: 26216611 pmcid: 4646752
Collins SL, Ashcroft A, Braun T, Calda P, Langhoff-Roos J, Morel O, Stefanovic V, Tutschek B, Chantraine F, European Working Group on Abnormally Invasive Placenta (EW-AIP). Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol. 2016;47:271–5. https://doi.org/10.1002/uog.14952 .
doi: 10.1002/uog.14952 pubmed: 26205041

Auteurs

Fusen Huang (F)

Department of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Chongqing, 400016, China. 793736612@qq.com.

Jingjie Wang (J)

Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, China.

Qiuju Xiong (Q)

Department of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Chongqing, 400016, China. xiongqiuju2003@163.com.

Wenjian Wang (W)

Department of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Chongqing, 400016, China.

Yi Xu (Y)

Department of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Chongqing, 400016, China.

Jia Zhuo (J)

Department of Information Center, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Chongqing, 400016, China.

Qiuling Xia (Q)

Department of Obstetrics and Fetal Medicine Unit, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Chongqing, 400016, China.

Xiaonan Liu (X)

Department of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Chongqing, 400016, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH